Advisory Committee on Immunization Practices (ACIP), 31490 [E8-12234]

Download as PDF 31490 Federal Register / Vol. 73, No. 106 / Monday, June 2, 2008 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of responses per respondent Number of respondents Average burden per response (in hours) Total burden (in hours) Form name Type of respondent Invasive Methicillin-resistant Staphylococcus aureus ABCs Case Report Form. ABCs Invasive Pneumococcal Disease in Children Case Report Form. Neonatal Group B Streptococcal Disease Prevention Tracking Form. State Health Department. 10 609 20/60 2030 State Health Department. State Health Department. 10 41 10/60 68 10 37 20/60 123 Total .................................................... .................................. ............................ ............................ ............................ 4918 Dated: May 23, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–12192 Filed 5–30–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Advisory Committee on Immunization Practices (ACIP) DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Centers for Disease Control and Prevention Public Health Service Act (PHS); Delegation of Authority jlentini on PROD1PC65 with NOTICES Notice is hereby given that I have delegated to the Director, National Center for Preparedness, Detection and Control of Infectious Diseases (NCPDCID), and the Director, Division of Global Migration and Quarantine (DGMQ), NCPDCID, with authority to redelegate, the authorities vested in the Director, Centers for Disease Control and Prevention, under sections 361(a), (b), (c), (d), and 362, Title III, of the PHS Act (Control of Communicable Diseases, 42 U.S.C. 264 and 265. The authority delegated under 361(a) does not include the authority to promulgate regulations. This delegation became effective upon date of signature. In addition, I have affirmed and ratified any actions taken by the Director, NCPDCID, the Director, DGMQ, NCPDCID, or their subordinates which involved the exercise of authorities delegated herein prior to the effective date of the delegation. Dated: May 20, 2008. Julie Louise Gerberding, Director, Centers for Disease Control and Prevention. [FR Doc. E8–12176 Filed 5–30–08; 8:45 am] BILLING CODE 4160–18–M VerDate Aug<31>2005 19:06 May 30, 2008 Jkt 214001 Centers for Disease Control and Prevention Times and Dates: 8 a.m.–6 p.m., June 25, 2008. 8 a.m.–5 p.m., June 26, 2008. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters to be Discussed: The agenda will include discussions on Rotavirus Vaccines; Combination Vaccines; MMRV Vaccine; Human Papillomavirus Vaccines; Pneumococcal Vaccines; Measles Outbreaks in the United States (2008); Adult Immunization Schedule; Anthrax Vaccine; Influenza Vaccines; Rabies Vaccine and Biologicals; Vaccine Supply; and Immunization Safety Update. There may be VFC voting on the Rotavirus, Combination and Human Papillomavirus Vaccines. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Antonette Hill, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E–05), Atlanta, Georgia 30333, Telephone (404) 639–8836, Fax (404) 639– 8905. The Director, Management Analysis and Services Office, has been delegated the PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Dated: May 27, 2008. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–12234 Filed 5–30–08; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food Safety Research; Investigations Focused on Promoting the Safety of Produce AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA-Center for Food Safety and Applied Nutrition (CFSAN)) is announcing the availability of approximately $1.0 million in research funds for fiscal year (FY) 2008. It is anticipated that individual grants will receive a total of $250,000 to $500,000 to cover both direct and indirect costs. These funds will be used to support research efforts to advance the safe transportation and preparation of produce and to help reduce the incidence of foodborne illness that may be associated with fresh produce consumption. The award will provide 18 months of support. There will be no additional years of noncompetitive continuation support. A copy of the full text of this announcement will be posted in Grants.gov and on FDA’s Center for Food Safety and Applied Nutrition Web site at https:// www.cfsan.fda.gov/list.html. Key Dates: Receipt Date: Applications are due within 90 days after the publication of the funding opportunity in the Federal Register. E:\FR\FM\02JNN1.SGM 02JNN1

Agencies

[Federal Register Volume 73, Number 106 (Monday, June 2, 2008)]
[Notices]
[Page 31490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-12234]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Times and Dates: 8 a.m.-6 p.m., June 25, 2008. 8 a.m.-5 p.m., 
June 26, 2008.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The agenda will include discussions on 
Rotavirus Vaccines; Combination Vaccines; MMRV Vaccine; Human 
Papillomavirus Vaccines; Pneumococcal Vaccines; Measles Outbreaks in 
the United States (2008); Adult Immunization Schedule; Anthrax 
Vaccine; Influenza Vaccines; Rabies Vaccine and Biologicals; Vaccine 
Supply; and Immunization Safety Update. There may be VFC voting on 
the Rotavirus, Combination and Human Papillomavirus Vaccines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Antonette Hill, 
Immunization Services Division, National Center for Immunization and 
Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta, 
Georgia 30333, Telephone (404) 639-8836, Fax (404) 639-8905.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and ATSDR.

    Dated: May 27, 2008.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-12234 Filed 5-30-08; 8:45 am]
BILLING CODE 4160-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.